CSL (OTCMKTS:CSLLY) Shares Gap Down – Here’s Why

CSL Limited Sponsored ADR (OTCMKTS:CSLLY)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $60.97, but opened at $57.22. CSL shares last traded at $59.7090, with a volume of 14,831 shares traded.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CSLLY. Zacks Research lowered shares of CSL from a “hold” rating to a “strong sell” rating in a research note on Tuesday, November 18th. Canaccord Genuity Group raised CSL from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 28th. Two analysts have rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, CSL currently has a consensus rating of “Buy”.

CSL Price Performance

The company has a quick ratio of 1.12, a current ratio of 2.46 and a debt-to-equity ratio of 0.50. The company has a fifty day simple moving average of $62.43 and a 200-day simple moving average of $71.98.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.